Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JonesTrading Upgrades Deciphera Pharmaceuticals to Hold

JonesTrading analyst Soumit Roy upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Sell to Hold.
byBenzinga Newsdesk
January 6, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

JonesTrading analyst Soumit Roy upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Sell to Hold.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Sorry Aaron Rodgers, But Lamar Jackson Could Become The Highest Paid Quarterback In The NFL

By Robert Kuczmarski
September 13, 1:56 PM
Former Heisman Trophy winner Lamar Jackson signed with the Baltimore Ravens as the final first-round draft pick in the 2018 NFL draft. When Jackson first signed with the Ravens, he entered into a four-year contract for approximately $9.5 million with signing bonuses included and a fifth-year exercisable option for a base salary of $23 million in 2022.

DKNG